Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension

Open Respiratory Medicine Journal

Volumn 3, Issue , 2009, Pages 53-60

  Ulrich, Silvia ^a   Hersberger, Martin ^a   Fischler, Manuel ^a   Huber, Lars C ^a   Senn, Oliver ^a   Treder, Ursula ^a   Speich, Rudolf ^a   Schmid, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chronic thromboembolic pulmonary hypertension; Hyperparathyroidism; Left heart failure; Osteopenia; Osteoporosis; Pulmonary hypertension

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; LEAN BODY WEIGHT; LUNG VASCULAR RESISTANCE; MALE; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; SECONDARY HYPERPARATHYROIDISM; URINALYSIS;

EID: 77953391104     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306400903010053     Document Type: Article

References (37)

1. Shane E, Silverberg SJ, Donovan D, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996; 101: 262-9.
2. Tschopp O, Boehler A, Speich R, et al. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2002; 2: 167-72.
3. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 13S-24S.
4. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5S-12S.
5. Badesch DB, McLaughlin VV, Delcroix M, et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 56S-61S.
6. McLaughlin VV, Sitbon O, Badesch DB, et al. Survival with firstline bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005; 25: 244-9.
7. Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 35S-62S.
8. Tschopp O, Schmid C, Speich R, et al. Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest 2006; 129: 1002-8.
9. Krall EA, Dawson-Hughes B. Walking is related to bone density and rates of bone loss. Am J Med 1994; 96: 20-6.
10. Gregg EW, Cauley JA, Seeley DG, et al. Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Int Med 1998; 129: 81-8.
11. Felson DT, Zhang Y, Hannan MT, et al. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 1993; 8: 567-73.
12. Aris RM, Neuringer IP, Weiner MA, et al. Severe osteoporosis before and after lung transplantation. Chest 1996; 109: 1176-83.
13. Humbert M, Trembath RC. Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J 2002; 20: 741-9.
14. Morse JH, Deng Z, Knowles JA. Genetic aspects of pulmonary arterial hypertension. Ann Med 2001; 33: 596-603.
15. Morse JH. Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Chest 2002; 121: 50S-53S.
16. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998: 26-37.
17. Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011-20.
18. Cenedese E, Speich R, Dorschner L, et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 2006; 28: 808-15.
19. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
20. Robinson RF, Nahata MC. Prevention and treatment of osteoporosis in the cystic fibrosis population. J Pediatr Health Care 2001; 15: 308-15.
21. Cunningham J, Sprague SM, Cannata-Andia J, et al. Osteoporosis in chronic kidney disease. Am J Kidney Dis 2004; 43: 566-71.
22. Roblin X, Bonaz B. Osteoporosis and inflammatory bowel disease. Am J Gastroenterol 2007; 102: 209; author reply 209-10.
23. Sanchez AJ, Aranda-Michel J. Liver disease and osteoporosis. Nutr Clin Pract 2006; 21: 273-8.
24. Conway S. Osteoporosis is cystic fibrosis. J Cyst Fibros 2003; 2: 161-2.
25. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003; 46: 64s-75s.
26. Borgstrom F, Zethraeus N, Johnell O, et al. Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 2006; 17: 637-50.
27. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997; 103: 197-207.
28. Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008; 135: 825-37.
29. Sambrook PN, Chen JS, March LM, et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004; 89: 5477-81.
30. Bjorkman MP, Sorva AJ, Tilvis RS. Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol 2008; 158: 749-53.
31. Rejnmark L, Vestergaard P, Heickendorff L, et al. Effects of longterm treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover. J Intern Med 2005; 257: 176-84.
32. Khouzam RN, Dishmon DA, Farah V, et al. Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci 2006; 331: 30-4.
33. Carlstedt F, Lind L, Wide L, et al. Serum levels of parathyroid hormone are related to the mortality and severity of illness in pa tients in the emergency department. Eur J Clin Invest 1997; 27: 977-81.
34. Kumbar L, Fein PA, Rafiq MA, et al. Pulmonary hypertension in peritoneal dialysis patients. Adv Perit Dial 2007; 23: 127-31.
35. Nasri H. Pulmonary artery pressure in association with serum parathormone in maintenance hemodialysis patients. Arch Med Sci 2006; 2: 32-5.
36. Boonen S, Broos P, Verbeke G, et al. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption. J Gerontol A Biol Sci Med Sci 1997; 52: M286-93.
37. Bischoff-Ferrari HA, Can U, Staehelin HB, et al. Severe vitamin D deficiency in Swiss hip fracture patients. Bone 2008; 42: 597-602.